OMALIZUMAB for Immune tolerance induction: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 18 adverse event reports in the FDA FAERS database where OMALIZUMAB was used for Immune tolerance induction.
Most Reported Side Effects for OMALIZUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| No adverse event | 9,736 | 15.3% | 0 | 3 |
| Asthma | 9,354 | 14.7% | 208 | 4,275 |
| Urticaria | 9,231 | 14.5% | 39 | 1,723 |
| Off label use | 9,199 | 14.4% | 100 | 627 |
| Dyspnoea | 8,323 | 13.0% | 133 | 3,674 |
| Drug ineffective | 6,747 | 10.6% | 57 | 1,465 |
| Cough | 5,926 | 9.3% | 86 | 2,751 |
| Pruritus | 5,224 | 8.2% | 32 | 1,202 |
| Fatigue | 5,053 | 7.9% | 94 | 1,826 |
| Malaise | 4,820 | 7.6% | 113 | 2,032 |
| Wheezing | 4,522 | 7.1% | 78 | 2,000 |
| Headache | 4,416 | 6.9% | 47 | 1,505 |
| Pneumonia | 4,251 | 6.7% | 133 | 2,318 |
| Pain | 3,605 | 5.7% | 46 | 1,198 |
| Nasopharyngitis | 3,421 | 5.4% | 48 | 1,472 |
Other Indications for OMALIZUMAB
Asthma (24,041)
Product used for unknown indication (14,050)
Chronic spontaneous urticaria (9,063)
Idiopathic urticaria (8,366)
Urticaria (5,500)
Urticaria chronic (1,064)
Food allergy (624)
Angioedema (412)
Hypersensitivity (364)
Rhinitis allergic (305)
Other Drugs Used for Immune tolerance induction
RITUXIMAB (207)
HUMAN IMMUNOGLOBULIN G (88)
ASPIRIN (62)
MYCOPHENOLATE MOFETIL (62)
ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT (53)
--BLOOD-COAGULATION FACTOR VIII FUSION PROTEIN WITH IMMUNOGLOBULIN G1 , ,-BIS WITH IMMUNOGLOBULIN G1 (52)
EFMOROCTOCOG ALFA (46)
PHLEUM PRATENSE POLLEN (36)
BORTEZOMIB (35)
OXALIPLATIN (33)